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ABSTRACT

EVIDENCE OF GENOTYPIC VARIATION, MHC CLASS I COPY NUMBER
VARIATION AND RECOMBINATION WITHIN THE CHICKEN MAJOR
HISTOCOMPATIBILITY COMPLEX-Y SYSTEM
Renee Therese Kopulos, Ph.D.
Department of Biological Sciences
Northern Illinois University, 2016
W.E. Briles and Melvin R. Duvall, Co-Directors

The major histocompatibility complex (MHC) is a gene region found in all jawed
vertebrates. These highly polymorphic, tightly linked genes are responsible for immune
regulation by presenting self and non-self antigens to the immune system. The MHC is the
most polymorphic vertebrate genome region because its genes face considerable selective
pressure since survival depends on the capacity to respond to bacterial, viral and parasitic
diseases. The MHC organization in different species has clearly evolved in separate and unique
ways since the time that birds and mammals diverged from a common ancestor ~310 million
years ago. The size and organization of chicken MHC genes is somewhat different from the
MHC regions found in mice and humans.
The history of the chicken MHC discovery began with a highly polymorphic blood
group system reported in 1950 by Briles, McGibbon and Irwin. This serologically-defined
system, originally designated as the chicken B alloantigen system, was subsequently identified
as the MHC locus through tissue graft compatibility experiments. The region renamed MHCB was mapped to chicken microchromosome 16. Briles and colleagues (1993) discovered
another group of MHC genes named MHC-Y. These genes also map to chromosome 16 but
are separated from MHC-B by a currently unmapped region. Chicken MHC-B haplotypes

strongly determine susceptibility or resistance to certain infectious diseases with additional
evidence that same may be true for MHC-Y.
Due to its more recent discovery and absence of a mammalian equivalent, little is
known about the MHC-Y. For this reason my project focused on this second MHC gene
cluster. MHC-B was first identified serologically through hemagglutination assays, and for
years it was routinely typed in this manner. The MHC-Y gene cluster remained undetected,
since MHC-Y molecules are either expressed at lower levels or do not appear on the chicken
red blood cell surface. . The MHC-Y system was first discovered through DNA hybridization,
hence it was originally called the Rfp-Y system, but then later changed. Sequencing revealed
MHC class I-like genes in MHC-Y. Early Southern hybridizations provided evidence for
MHC-Y polymorphism. The MHC-Y class I (YF) architecture is similar to that of the classical
MHC-B class I (BF) molecule. However, instead of binding peptides, the YF molecule
possesses a narrow, hydrophobic binding groove that binds non-peptidic ligands.
The first project objective was to gain insight into the MHC-Y genotypic diversity. I
examined nine different layer stocks of Leghorn origin including a Leghorn line maintained
at Northern Illinois University, a University of Arkansas experimental line, and seven lines
from an international company breeding egg laying chickens. I examined their MHC-Y
haplotypes using Southern blots. Multiple DNA samples representing all nine lines were
digested with Bgl I and hybridized with a MHC-Y class I region specific probe (163/164f). .
The blots revealed extreme MHC-Y polymorphism among the haplotypes present in the nine
lines. Some haplotypes are very simple with only two or four fragments, whereas others have

as many as 12 hybridizing fragments. These data suggest that MHC-Y haplotypes may
contain a range of class I genes.
Next, to obtain a more direct measure of sequence variability, I examined MHC-Y class
I locus exons 3 and 4 using denaturing gradient gel electrophoresis (DGGE). Another goal of
employing DGGE was to develop a more convenient method for determining MHC-Y
haplotypes to replace expensive, time consuming, and radioactive Southern hybridizations.
These assays also provided additional data supporting the likelihood of different numbers of
MHC-Y class I genes across multiple haplotypes.
To further investigate Y class I gene copy number variation between different
haplotypes, I analyzed the NIU haplotypes in this study using quantitative PCR (qPCR). This
third technique confirmed that significant copy number differences occur in certain MHC-Y
haplotypes. Among the MHC-Y haplotypes examined from the NIU line, haplotype Y3 seems
to have a higher YF loci copy number compared with all others.
Given the wide variability in gene numbers revealed in this study, I wanted to determine
whether genetic recombination, crossing over, in the MHC-Y region might be contributing to
haplotypic variation. YF molecules seem to have a high recombination frequency between its
multiple copies, perhaps on the order of 1% (1 map unit) or higher. This may be due to many
similar genes present within the MHC-Y region. Proximity of a 41 base pair repeat known as
PO41 might also contribute to instability of the region.

NORTHERN ILLINOIS UNIVERSITY
DE KALB, ILLINOIS

MAY 2016

EVIDENCE OF GENOTYPIC VARIATION, MHC CLASS I COPY
NUMBER VARIATION AND RECOMBINATION WITHIN
THE CHICKEN MAJOR HISTOCOMPATIBILITY
COMPLEX-Y SYSTEM

BY

RENEE T. KOPULOS
© 2016 Renee T. Kopulos

A DISSERTATION SUBMITTED TO THE GRADUATE SCHOOL
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS
FOR THE DEGREE
DOCTOR OF PHILOSOPHY
DEPARTMENT OF BIOLOGICAL SCIENCES

Doctoral Co-Directors:
W.E. Briles
Melvin R. Duvall

ACKNOWLEDGEMENTS
I would like to thank all those who provided me with assistance in completing my PhD. I
am extremely grateful to Dr. and Mrs. Briles, who over the years taught me too many lessons to
count, but among those were how to be a good scientist as well as good human being. I
sincerely thank Dr. Robert Taylor for his guidance, support, and encouragement over the many
years. To those who have welcomed me into their homes and their laboratories, David Briles,
Janet Fulton, and Marcia Miller, thank you for your support and guidance as well. Thank you to
my committee, especially Mel Duval for all the care and assistance you have provided me to
complete this project. Special thanks to my family for their unconditional love and support, my
brothers George Kopulos and Kenny Kopulos and their families, and my Mom and Dad, Danuta
and George Kopulos. And finally thank you to my love Edwin Gamez for more than I can ever
say.

DEDICATION

In loving memory of Dr. Worthie Elwood Briles and Mrs. Clara Ruth Briles, you remain in the
minds and hearts of those who were blessed enough to know you.

TABLE OF CONTENTS

Page

LIST OF TABLES ................................................................................................................. vii
LIST OF FIGURES............................................................................................................... viii
Chapter
1.

IMMUNE SYSTEMS AND THE MAJOR HISTOCOMPATIBILITY
COMPLEX ................................................................................................................... 1
Discovery of the MHC ............................................................................................. 2
Genomic Features of the MHC................................................................................. 3
MHC Haplotypes…………….................................................................................. 5
Chicken B System .................................................................................................... 6
Chicken Class I........................................................................................... 9
Chicken Class II.......................................................................................... 11
Chicken Class III........................................................................................ 13
Chicken Class IV........................................................................................ 13
Haplotyping the MHC in Chicken.......................................................................... 15
Chicken MHC-Y..................................................................................................... 16

v

Chapter

Page
MHC-Y Structure................................................................................................... 17
MHC-Y Expression................................................................................................ 20
MHC-Y Effect on Host Response to Pathogens..................................................... 20
Recombinational Hotspot - GC Rich Region Containing PO41 Repeat Sequence. 22
MHC-Y Variability is Naturally Higher Than That of MHC-B............................. 23
Copy Number Variation.......................................................................................... 23

2. CHARACTERIZATION OF THE CHICKEN MHC-Y SYSTEM USING
SOUTHERN BLOT ANALYSIS................................................................................. 26
Introduction ............................................................................................................ 26
Materials and Methods............................................................................................ 27
DNA............................................................................................................... 27
RFLP Procedure.............................................................................................. 27
Labeling of 163/164f Probe............................................................................ 29
Southern Blots................................................................................................. 30
Results............................................................................................................. 31
Recombination Can Be Observed in the Southern Blots............................... 43
Evidence of Recombination in the NIU Line................................................ 43
Copy Number Variation Can Be Observed in Southern Blots...................... 44
Future Research............................................................................................. 44

vi

Chapter

Page

3. EXAMINING ALLELIC COPY NUMBER VARIATION IN THE CHICKEN
MHC-Y USING PCR-DGGE....................................................................................... 46
Introduction........................................................................................................... 46
Materials and Methods............................................................................................ 47
Primer Design............................................................................................. 47
Building Gel Assembly............................................................................... 49
DGGE......................................................................................................... 52
Results.................................................................................................................... 53
Conclusion.............................................................................................................. 60
4. QUANTITATIVE REAL-TIME PCR......................................................................... 61
Materials and Methods............................................................................................ 61
Results............................................................................................................. 64
Conclusion...................................................................................................... 78
5. SYNTHESIS ............................................................................................................... 79
LITERATURE CITED ......................................................................................................... 81

LIST OF TABLES

Table

Page

1.

DGGE Primers............................................................................................................ 48

2.

DGGE Gel Composition............................................................................................. 50

3.

DGGE Polymerization Reagents................................................................................ 50

4.

Primers for qPCR....................................................................................................... 62

5.

qPCR Results Exon 2................................................................................................. 66

6.

qPCR Results Exon 3................................................................................................. 68

7.

qPCR Results Exon 4................................................................................................. 70

8.

qPCR Results Exon 5................................................................................................. 72

9.

qPCR Results First Half of Probe............................................................................... 74

10. qPCR Results Second Half of probe........................................................................... 76

LIST OF FIGURES

Figure

Page

1.

Map of the MHC-B Region........................................................................................... 8

2.

MHC Class I Molecule................................................................................................ 10

3.

MHC Class II Molecule............................................................................................. 12

4.

Location of MHC-Y on Chromosome 16................................................................... 18

5.

NIU MHC-Y Haplotypes 2002.................................................................................. 32

6.

NIU MHC-Y Haplotypes 2007.................................................................................. 33

7.

Arkansas MHC-Y Haplotypes.................................................................................... 34

8.

Commercial Line 1 MHC-Y Haplotypes.................................................................... 35

9.

Commercial Line 2 MHC-Y Haplotypes.................................................................... 36

10.

Commercial Line 11 MHC-Y Haplotypes.................................................................. 37

11.

Commercial Line 13 MHC-Y Haplotypes.................................................................. 38

12.

Commercial Line 16 MHC-Y Haplotypes.................................................................. 39

13.

Commercial Line 19 MHC-Y Haplotypes.................................................................. 40

14.

Commercial Line 22 MHC-Y Haplotypes.................................................................. 41

15.

Commercial Line 22 MHC-Y Haplotypes.................................................................. 42

16.

Recombination Event in NIU Family 619.................................................................. 45

17. DGGE YF Primers on 40-55% Denaturing Gel.......................................................... 54
18. DGGE YF Primers on 40-65% Denaturing Gel.......................................................... 55

ix

Figure

Page

19. DGGE Exon 2 Primers on 45-70% Denaturing Gel................................................... 56
20. DGGE Exon 3 Primers on 45-70% Denaturing Gel................................................... 57
21. DGGE Exon 4 Primers on 40-70% Denaturing Gel.................................................... 58
22. DGGE Exon 5 Primers on 60-75% Denaturing Gel.................................................... 59
23. Exon 2 Copy Number Variation.................................................................................. 67
24. Exon 3 Copy Number Variation.................................................................................. 69
25. Exon 4 Copy Number Variation.................................................................................. 71
26. Exon 5 Copy Number Variation.................................................................................. 73
27. First Half of Probe Copy Number Variation............................................................... 75
28. Second Half of Probe Copy Number Variation.......................................................... 77

CHAPTER 1

IMMUNE SYSTEMS AND THE MAJOR HISTOCOMPATIBILITY COMPLEX

Two systems of immunity are found in vertebrates: innate and adaptive immunity. Innate
immune system cells such as macrophages and dendritic cells circulate throughout the body
while expressing evolutionarily conserved receptors that recognize antigens common to
microorganisms, known as path-associated molecular patterns (PAMPs). Recognition results in
fragmentation of the invading pathogen, inflammation and pathogen clearance (Delves & Roitt,
2000).
In adaptive immunity, MHC molecules process antigenic peptides in the cytosol of the
cell and present their proteins on the surface of the cell. T lymphocytes bind to the MHC
molecule and determine if the peptide is a non-self protein. If the peptide is determined to be
foreign, the T cell it will either destroy the cell, or secrete cytokines signaling the B cells to
release antibodies and macrophages.
B and T cells express highly diverse and very specific antigenic receptors that can
recognize a wide range of pathogens and generate memory cells to help prevent reinfection. The
receptors on B and T lymphocytes are generated by gene rearrangement providing each
lymphocyte unique specificity. B cells produce antibodies that eliminate extracellular
pathogens. T lymphocytes are classified into two major categories; CD8+ T cells and CD4+ T
cells. These cells recognize antigens bound to the grove of class I and class II MHC proteins
respectively. CD8+ T lymphocytes, known as T cytotoxic cells, are involved in lysis of virally
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infected cells, cancer cells or cells that have suffered some type of damage. In contrast, CD4+
lymphocytes are known as helper T cells. They provide help to effector cells such as B cells and
T cytotoxic cells by secreting cytokines signaling the B cells to release antibodies and
macrophages, and signaling T cells to kill infected cells.
MHC molecules were originally found to be the determinate proteins involved in tissue
rejection, hence the name Major Histocompatibility Complex. (Delves and Roitt, 2000)

Discovery of the MHC
In 1951 George Snell, Nobel Prize Laureate, became interested in the genetic loci that
caused graft rejection of tumors transplanted onto mice (Klein, 2001). He called them the
Histocompatibility loci, or H loci. Snell was able to determine that there were many H loci,
although they were difficult to distinguish. Snell found that the mutation responsible for fusion
of tail vertebrae (Fu) was linked to a particular H haplotype and was able to use this visible
marker in tracking the segregation of the H haplotype (Klein, 2001).
While Snell was elucidating the MHC in mice, a technician in the Department of
Medicine at Stanford University School of Medicine named Rose O. Payne realized
agglutinating reactions with sera from patients she was studying were likely the result of
inadvertent immunization via blood transfusions. This finding allowed her and Walter Bodmer
to identify a series of antigens, which they called LA, and now make up the HLA or Human
Leukocyte Antigen system, which is the name of the MHC system in humans (Klein, 2001).
Around the same time Briles, McGibbon and Irwin published an article in Genetics (W.
E. Briles, McGibbon, & Irwin, 1950) describing a red blood cell alloantigen system in the
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chicken, designated the B system. Briles and colleagues continued to develop an understanding
of the complexity and breadth of the system over the next ten years, at which point it was
determined that the B system was the very likely the MHC in chickens since it determined the
outcome of skin graft rejection (Schierman & Nordskog, 1961).

Genomic Features of the MHC
The technological development of genomic sequencing allowed the broad complexity of
the MHC to be viewed for the first time. About 40% of the genes in the MHC are associated
with known immune system functions. The functions of many genes, including the highly
conserved “framework genes” remain to be fully appreciated. The MHC is of biomedical
interest due to its role it has in transplant rejection. For this reason there is much detailed
information on human MHC class I and class II gene polymorphism, and slowly the role of the
MHC in human disease being discovered. It is now clear that the HLA influences resistance and
susceptibility to infectious disorders and the propensity for humans to develop autoimmune
diseases (Gruen & Weissman, 1997).
MHC class I and class II histocompatibility genes are the most polymorphic genes within
the genome. Variation is mostly confined to the portion gene sequence encoding the peptidebinding groove of these mature class I and class II molecules. Allelic variability determines the
range of peptides that are presented by MHC class I and class II. Individual MHC class I and
class II molecules exhibit broad specificities in the types of peptides they can bind and present to
T cells. In addition to serving in peptide antigen presentation, the MHC class I molecules also
serve as ligands for receptors on natural killer cells. Class I molecules are expressed on the
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surface of almost all cells, and class II molecules are typically on professional antigen presenting
cells but may appear on other cells as well during immune responses. Other genes in the MHC
complex are involved other aspects of the immune response. Genes in the class III region are
responsible for regulation of the inflammatory reaction and components of the complement
cascade (Vandiedonck & Knight, 2009).
Due to the important role the MHC plays in immune function and its genetic complexity,
the human MHC was one the first multi-megabase regions to be fully sequenced (The MHC
Sequencing Consortium, 1999). It is the most gene dense region of the human genome with one
gene per 16kb, including pseudogenes. Currently the MHC serves as a model region in
genomics establishing fundamental concepts of linkage disequilibrium, haplotype structure and
meiotic recombination(Vandiedonck & Knight, 2009). The HLA system in humans is located
on Chromosome 6, and spans over 4 Mb. The HLA regions are divided into class I, class II and
class III, with extended class I and class II regions on either side spanning 7.6 Mb (Trowsdale,
2001). The MHC class I and class II regions have been duplicated several times generating new
gene family members over evolutionary time (Vandiedonck & Knight, 2009). It is especially
apparent that MHC class I genes undergo an evolution through duplication and divergence.
There appears to be a cycle of class I gene birth and death such that few, if any, orthologs are
maintained across species. Duplications allow pseudogenes to form and as a result new alleles
may become secondarily active through gene conversion. The extreme polymorphism found in
the MHC region of the human genome is unparalleled, with more than 15,000 alleles described
by the year 2000, attributed to point mutations, recombination and gene conversion. When an
individual possesses heterozygous genes at the class I and class II loci it will allow for a more
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diverse immune response, for this reason polymorphism in the MHC is most likely selected for.
Rare alleles may provide a selective advantage allowing those individuals who possesses them
to survive and to perpetuate the species. Known structural variation in the human MHC includes
a total of two inversions, 63 indels and 181 copy number variants (Vandiedonck & Knight,
2009).

MHC Haplotypes
The term haplotype is used when referring to MHC alleles at multiple loci that are
transmitted together in linkage from the same chromosome. In the human genome it is observed
that multiple blocks of long conserved sequences, sometimes spanning the entire classical MHC
region, are inherited together at relatively high frequencies within populations (Vandiedonck &
Knight, 2009). Haplotypes differ in gene composition and size appear to be the result of nonallelic homologous recombination (Trowsdale 2002).
Certain conserved HLA haplotypes are called Ancestral Haplotypes (AH). The central
genes include the C4, C2, Bf, 21 hydroxylase (Cyp 21), TNF, BAT and other genes. 30 unique
AH have been identified; each has similar length, allele content, and similar deletions and
duplications. AHs that contain large deletions are associated with autoimmune diseases (Gruen
& Weissman, 1997).
It appears that the MHC has a conserved “block structure” with non-class I and non-class
II genes providing a framework in which the MHC genes undergo expansion in different
species, but still maintain a basic overall orthology (Amadou, 1999). Studies of diseases such as
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malaria, AIDS, type 1 diabetes, rheumatoid arthritis, multiple sclerosis as well as other autoimmune diseases have been linked to sub-regions within the MHC (Traherne et al., 2006).
Discerning the MHC haplotypes of the human genome, and the genes linked to disease has
proven to be difficult due to the extreme levels of polymorphism, gene density and the lack of
sufficient data from fully pedigreed multi-generational families. This idea of linkage
disequilibrium (LD), interacting groups of MHC alleles reshuffling in modular blocks, may
contribute to the difficulties in identifying individual genes in disease causation (Traherne et al.,
2006).
Quantization of gene copy number within the MHC may be one way to implicate certain
genes and their links to human disease, especially those that cause problems with auto-immunity
(Wen Jie Zhang et al 1990).

Chicken B System
All vertebrates have some form of a major histocompatibility complex (Kaufman 1990),
but the chicken is unique in its extremely strong association with MHC haplotype, and disease
resistance or susceptibility (W E Briles, Stone, & Cole, 1977). Another unique feature of the
chicken genome is that MHC genes are found in 2 separate clusters on microchromosome 16;
the MHC-B locus, also known as the classical MHC, and the MHC-Y locus.
Prior to the discovery of the MHC-Y gene region, the MHC-B region was referred to by
Kaufman as the “minimal MHC”, spanning only 92kb and containing 19 genes (Kaufman et al.,
1999). Current thinking puts the entire chicken MHC genome size at 3-7 Mb and containing
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200-400 genes and pseudogenes (Chaves, Krueth, & Reed, 2009). As the landscape of the
chicken MHC is being elucidated, we are finding that it is more complex than once thought, and
possibly comparable in size to the human MHC which is 3.6 Mb in length, and contains 224
genes. (Kulski, Shiina, Anzai, Kohara, & Inoko, 2002). Certain genes that are found in the
human MHC are lacking in the chicken genome, such as low molecular mass protein (LMP),
class II and many class III genes. The chicken contains MHC genes that are not found in
humans, such as the B-G genes and NK-cell receptor genes (Kaufman, 2000).
An extended gene map of the Red Jungle Foul (RJF) MHC-B region had been developed
by Shiina et al., (2007). It is 242 kb in size and includes 46 genes. (Shiina et al, 2007) This map
does not include the MHC-Y cluster (Fig. 1).
The MHC-B is located on microchromosome 16 along with the MHC-Y system, and the
only Nucleolar Organizer Region (NOR) in the genome (Delany, Robinson, Goto, & Miller,
2009).
The MHC-B system is complex, gene dense, and was thought to recombine at a low rate,
although new molecular studies are finding that the recombination rate is much higher than
previously thought (J. Fulton, personal communication). New evidence also suggests that some
common B haplotypes may actually be recombinants (Hala et al., 1988). As a result, other
immunity and non-immunity genes contained within the B complex have co-evolved with the
class I, class II and class IV alleles. Some of these genes, such as TAP1, TAP2 and tapasin have
co-evolved with the dominant class I BF2 molecule, which is transported and expressed on the
cell surface at a higher rate than the BF1 molecule (Wallny et al., 2006).
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The MHC-B system genotype strongly influences infectious disease outcomes in the
chicken. The haplotype B21 is associated with resistance to Marek’s Disease, while the B19
haplotype is associated with susceptibility (Briles 1977). Experiments were conducted to
establish whether MHC-B genes that determine resistance to RSV-induced tumors would also
influence resistance to Marek's disease and lymphoid leukosis. Matings of line 63 x 151 F3 or F4
breeders segregating for the MHC-B system were made to produce B2B2, B2B5, and B5B5
chicks. The chicks were infected with a standard inoculum of one of the three tumor viruses in
separate experiments. The B2 haplotype from 63 conveyed greater resistance to tumors induced
by all three viruses than the B5 from 151 chickens. This finding suggests that genes of the MHCB system may determine a general ability to resist tumor formation or cause tumor regression
(W E Briles et al., 1977).

Chicken Class I
Class I genes of the chicken MHC-B system are designated BF, and are homologous to
class I genes in mammals (Pink, Droege, Hála, Miggiano, & Ziegler, 1977). Class I molecules
are found on the surface of all nucleated cells. Proteins are degraded in the cytosol of the cell by
the proteasome. The MHC binds these peptide fragments and displays on them on the surface
membrane of the cell for the T lymphocytes to bind.
A class I molecule is heterodimer made up of alpha chain, also called the heavy chain,
and a beta 2-microglobulin molecule (2m) (Figure 2).The alpha chain consists of three domains
the alpha 1 (1), alpha 2 ( 2) and alpha 3 (. The anddomainsfold to make up the
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peptide binding grove which presents the antigen to T-cells. The a3 domain associates with the
2m. Association with 2m and antigen binding are necessary for the MHC molecule fold
properly for presentation on the cell surface (Janeway et al., 2001).

Figure 2. MHC class I molecule (Parham, 2005)
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It is currently unknown how many total functional class I genes are found in the chicken.
Although the BF1 and BF2 class I genes in the chicken both express a gene product, it has been
reported that the BF2 mRNA transcripts are found to be two to five fold higher than BF1
transcripts, meaning that the BF2 gene is expressed on the cell surface at a much higher rate than
BF1. (O’Neill, Livant, & Ewald, 2009). In the MHC-Y, one haplotype has been found to have at
least three functional class I molecules (M.M. Miller personal communication).
The most recent ancestor of the chicken, red jungle fowl, are found to have 11 functional
class I-like genes (Davison, Kaspers, Schat, & Kaiser, 2011). The organization of the Japanese
quail MHC is similar to that of the chicken, but it also has undergone duplication in several of its
MHC regions (Davison et al., 2011). Five functional class I MHC genes have been found in the
duck, which diverged earlier from the Galloanseriforme lineage (van Tuinin, M 2001). Both
ducks and chickens are found to have one class I gene that is predominantly expressed at a high
level. Humans and other mammals have 3 class I alleles that are able to contribute a broad
spectrum of peptides, lending to higher diversity for the class I portion of the immune system
(Kaufman 1999). Findings show that the binding motifs of chicken class I molecules differ
significantly from that of mammalian class I models (Wallny et al., 2006).

Chicken Class II
MHC class II molecules are expressed on Antigen Presenting Cells (APCs) such as B
cells, monocytes, macrophages, dendritic cells and stimulated T cells. The class II molecules
are heterodimers composed of proteins from  and  genes (Chaves et al., 2009). The class II
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and classII genes code for highly polymorphic peptide binding regions (PBR) known as the 1
and 1 domains. Environmental pathogens may have influenced the generation of these
polymorphisms through positive selection and gene conversion (Hosomichi et al., 2006). The
genetic organization and structure of the functional chicken class II genes are strongly
conserved between mammals and birds, although the overall topography of the chicken class II
region has undergone considerable changes (Zoorob, Béhar, Kroemer, & Auffray, 1990).

Figure 3. MHC class II molecule (Parham, 2005)
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The chicken genome contains a single class II gene, which is monomorphic and located
5cM (~approximately 5 million basepairs) outside the chicken B locus. There are two chicken
class II (BL-B) genes expressed in the BF/BL region of the B locus, known as the BL-B major
gene and the BL-B minor gene, with both genes on either side of the tapasin gene (Jacob,
Milne, Beck, & Kaufman, 2000). There is some evidence that suggests that there may be a BL-B
gene outside the B locus (Zoorob, Bernot, Renoir, Choukri, & Auffray, 1993). It is currently
unknown how many functional class II genes are in the MHC-Y cluster in the chicken genome.

Chicken Class III
Two genes representative of a class III region were found in the chicken genome in 2007
(Shiina et al.), prior studies failed to locate class III orthologs in the chicken. The class III like
gene CYP21 found in the chicken, is similar to HLA cytochrome P450 with 57% similarity, and
TNXB in the chicken is similar to HLA Tenascin-X precursor with 58% similarity. These two
genes are found downstream from C4 and CenpA and just upstream of LTB4R1. This five gene
unit is similar to a group of genes found in the HLA that play a role in regulating inﬂammation
(Shiina et al., 2007).

Chicken Class IV
The fourth multigene family found in the chicken MHC is known as the BG genes which
encode MHC Class IV molecules. This locus is significant because it was most likely the BG
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antigens that were recognized serologically in the discovery of the MHC-B system (W. E. Briles
et al., 1950).
The BG genes of the chicken are similar to the B7/butyrophilin-like group found in the
extended MHC of humans regulating T- cell activation and tolerance. (Rhodes et al., 2001).
Butyrophilin-like genes of human and the BG genes of the chicken share a 40% amino acid
identity and a related IgV-like domain (Salomonsen et al., 1991).
There is one single BG gene, BG0, located on Chromosome 2 in the chicken, and another
single BG gene, BG1, located in the BL region of the B system genes on Chromosome 16.
Nearby the BG1 gene on Chromosome 16 is a immunoglobulin superfamily of highly
polymorphic BG genes in a tandem array, that are found to undergo rapid evolutionary change
in response to pathogen variation (Salomonsen et al., 2014). The BG genes were first known to
be expressed on erythrocytes, but are now known to be expressed in all important immune
system cells as well as in the bursa, thymus and intestine (Salomonsen et al., 2014).
The BG1 gene is associated with resistance to Marek’s disease, and the interruption of
this gene by an insert sequence, is associated with Marek’s susceptibility (Goto et al., 2009).
The BG1 molecular structure resembles that of a tyrosine-based inhibitory receptor. It undergoes
tyrosine phosphorylation in the presence of Pervanadate, and associates with SHP-2, a signaling
phosphatase, indicating that it is involved in inhibitory signaling limiting cell activation. (Goto
et al., 2009).
BG proteins have been found in the intestinal epithelial cells of the chicken. Upon
discovery the BG protein was called a zipper protein, because it contained 27 repeats that began
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with leucine. It was found to resemble tropomyosin, and regulates myosin binding to actin in the
intestinal microvillus (Bikle, Munson, & Komuves, 1996).

Haplotyping the MHC in Chicken
The Major Histocompatability Complex in the chicken was detected by alloimmune
hemagglutinating reagents in 1947 by Briles and Briles and designated the B system. The name
symbolizes that the MHC was the second blood group system discovered in the chicken (W. E.
Briles & Briles, 1982). To detect blood group systems in the chicken, reagents were created by
injecting blood from one chicken (donor), into another (recipient). This was done usually to
several chickens, and called an immunization series. After fivein days, a small amount of plasma
from each recipient was tested on donor blood to determine whether the bird mounted an
immune response to the donor erythrocytes. If the recipient bird created antibodies to the
donor’s red cells, agglutination could be seen in the glass tube and under a microscope. If strong
agglutination was detected a larger amount of blood was collected from the recipient bird to be
analyzed and possibly used as a typing reagent. Haplotype identification using serological tests
served as the basis for identification until techniques using DNA were developed. Serology
currently can be used as a rapid way to identify chicken haplotypes in a population (W. E. Briles
et al., 1950).
There are many techniques other than serology that can be used to characterize
immunological diversity in chickens, and often it is necessary to combine more than one
technique to get an accurate estimation of genetic variation in a population (Bauer & Reed,
2011). Other techniques used in the Briles lab to haplotype the MHC in chickens include the use
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of Southern blots/ Restriction Fragment Length Polymorphism (RFLP), Single Strand
Conformation Polymorphism (SSCP) genotyping microsatellite locus LEI0258, and Denaturing
Gradient Gel Electrophoresis (DGGE).

Chicken MHC-Y
The second MHC gene cluster in chicken, originally called Rfp-Y, was discovered by
chance in 1992 when Miller noticed inconsistencies between haplotypes determined by
serological means, and haplotypes determined by means of RFLP using probes specific for class
I and class II MHC alleles in chicken (W. Elwood Briles, Goto, Auffray, & Miller, 1993).
Additional fragments on the Southern blots did not segregate with the MHC-B types. Briles
suggested to Miller that these additional genes may be a completely different system from the B
system, and it was soon discovered there are, in fact, two distinct clusters of MHC genes both
located on Chromosome 16 in the chicken (W. Elwood Briles et al., 1993). This region is now
designated the MHC-Y system. These two clusters of MHC genes are located on the same
microchromosome that contains the only nucleolar organizing region (NOR) in the chicken. The
organization of the two MHC systems with respect to the NOR has only recently been
determined on the microchromosome (Delany et al., 2009).
The functional importance of the MHC-Y has been in question ever since its discovery.
Attempts to produce polyclonal antisera to the system failed, which raised the question whether
the MHC-Y genes were expressed (Hunt, Goto, Foster, Bacon, & Miller, 2006). In 2003
Thoraval et al. showed that MHC-Y genes do express one or more loci, and are transcribed in
essentially all the organs of the chicken.
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Mapping this new cluster of MHC genes to the chicken genome proved to be difficult.
Using two different mapping populations, the Y system failed to associate with over 400
markers that were tested (Miller et al., 1994). A line of birds that had multiple copies of the
MHC/NOR chromosome was cleverly used to determine that the Y system was in fact on the
same chromosome as the B. The Cornell Trisomic strain of chickens was a genetic line
developed with individual birds having a trisomic condition for microchromosome 16, yet the
offspring were still viable and fertile. By crossing 2 individuals of the trisomy 16 line, a ratio of
1:2:1 was generated of disomic/trisomic/tetrasomic chickens, which allowed the investigators to
observe different intensities of bands on Southern blots, depending on the chromosome number,
using probes specific to the MHC-B and NOR. Probes that bound other genes linked to
chromosome 16 would exhibit different dosage intensities as well, as was the case for the MHCY system. In 1996 the Y system was assigned to microchromosome 16 by Miller et al., (1996).

MHC-Y Structure
MHC-Y class I loci are 73% similar in coding region to the class I genes of the B system,
and are transcribed in nearly all organs. MHC-Y molecules have been demonstrated to express
in vivo. The arrangement of the two separate regions of MHC genes supports the idea that the
MHC genes diversify rapidly in avian species (Kellie et al. 2005, Shiina 2004).
To date more than 17 Y haplotypes have been identified through RFLP comparisons
(Miller et al. 2004).
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Figure 4. Location of MHC-Y relative to MHC-B on Chicken Microchromosome 16 (Delany et
al., 2009).
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The structure of the YF1*7.1 molecule was solved by Hee et al., in 2009 through X-ray
crystallographic analysis. In comparison to that of the classical MHC-B molecule, the YF1*7.1
molecule has been found to have a narrower binding groove than the classical BF MHC class I
molecule, lined with 16 hydrophobic residues out of 30 total. The YF1 molecule structure is
closely related to the MHC-BF2 classical mammalian as well and non-mamalian class I heavy
chains. Despite the similarity to the BF2 molecules in the chicken the YF1*7.1 binding cleft is
not optimized for peptide presentation, but rather medium sized, non-peptidic ligands due to its
hydrophobic character (Hee et al., 2009).
In comparison to typical mammalian MHC class I molecules the YF1*7.1 begins
dissociating at 40°C which is 1.8°C lower than a chickens average body temperature, indicating
that the YF*7.1 molecule may be disassociated unless there is a ligand present in its binding
cleft (Hee et al., 2009).
The authors of the study have found the YF1*7.1 ligand to be an antiseptic cationic
surfactant called hexadecyltrimethylammonium (also called centrimonium), although they were
unable to definitively identify the ligand through mass spectrometry. By examining the structure
of the YF1*7.1 protein it has been determined that the natural ligand for the YF1 protein is most
likely a lipid, in contrast to the natural ligands of the MHC-B system which are much larger
peptides (Hee et al., 2010).
The current hypothesis is that MHC-Y molecule binds products of bacterial metabolism,
similar to MR1 molecule in humans, though the products are most likely lipids instead of
metabolites. Preliminary evidence through mass spectrometry indicates the YF1 ligand is a
glycerophospholipid of microbial origin (M. Miller, personal communication).

20

MHC-Y Expression
Gene activity in the Y region is poorly understood. Afanassieff et al. (2001) determined
that although two YF loci were found in the CB chicken line, only one YF gene was transcribed,
YF1, while the other was found to be disrupted and unexpressed. The YF1 heavy chain (HC) is
closely related to the chicken MHC-B class I HC and mammalian MHC class I HC but not to
non-classical CD1 HC. Thoraval et al., (2003) found evidence for two different transcripts in
three different MHC- Y haplotypes with evidence that there may be one or more additionally
expressed loci (Afanassieff et al., 2001).

MHC-Y Effect on Host Response to Pathogens
Studies indicate that the MHC-Y plays an intermediate role in allograft rejection
(Thoraval et al., 2003) and seems to complement the MHC-B complex rather than duplicate it. It
has been shown that when the MHC-B systems are defined as identical, but MHC Y systems
differ, skin graft rejection takes place within 15 days, two times longer than if the MHC B
systems differ.
In 1996 an experiment was conducted by (Wakenell, Miller, Goto, Gauderman, & Briles,
1996) using the NIU chicken line with previously determined MHC-B and MHC-Y haplotypes;
the birds were challenged with Marek’s disease virus (MDV) strain RB1B. The MHC-B
haplotypes were serologically typed, B11 and BR9. Three MHC-Y haplotypes, Y1, Y2, and Y3
were identified using a Y system specific probe 163/164f in the challenge population. The result
of this study showed that birds with the MHC-Y genotype Y3/Y3 had 2.3 times the risk of MDV
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tumor formation, compared with birds with other MHC-Y genotypes combined. Following this
outcome, two studies published in the next two years failed to find a similar association in their
lines (Vallejo et al., 1997) (Lakshmanan & Lamont, 1998). However, these studies used
different MDV virus strains and were conducted in chicken populations having different MHCY haplotypes from the NIU population.
The first study that did not show an association between Marek’s outcome and MHC-Y
haplotypes was published in Animal Genetics by (Vallejo et al., 1997). It looked at inbred lines
63 and 72. Line 63 is resistant to MDV and found to be homozygous for MHC-Y having the
genotype Y11/Y11. Line 72 is susceptible to MDV and the MHC-Y genotype is Y12/Y12. Lines
63 and 72 had a similar number of bands on the Southern blot images provided, indicating both Y
haplotypes contained similar copy numbers of the MHC-Y alleles. This study did find a
tendency for the Y12 allele to favor high incidence to MDV, but it was determined to not be
significant (Vallejo et al., 1997).
In the second study, (Lakshmanan & Lamont, 1998) tested four lines called 1High,
1Low, 2High and 2Low, indicating selection for multitrait immunocompetence . Chicks were
inoculated with Md5 MDV. The probe used to determine Y types was 18.1, a probe specific to
the MHC-Y class II (YL) region. This probe has been shown to give a limited number of
fragment polymorphisms when tested on the NIU line (M. M. Miller et al., 1994). In this study
MHC-Y banding patterns consisted of 2 or 3 fragments per bird. This study showed no
significant differences among the 3 Y types and MD incidence.
The MHC-Y system also had an influence in the outcome of Rous Sarcoma Virus (RSV)
induced tumors (LePage, Miller, Briles, & Jr, 2000). Six week old chicks were challenged in the

22

wing-web with RSV. Tumor scores were taken over a ten week period. The MHC-B genotype of
the all chicks in the study was B2B5. The challenge was designed using this B type, because it
was known to confer intermediate tumor growth which would help facilitate detection of MHCY influence on the tumors.
The five MHC-Y genotypes that were considered in the study were Y1.1/Y1.2,
Y1.2/Y1.2, Y1.1/Y6, Y1.2/Y6, and Y6/Y6. MHC-Y genotypes were found to have significantly
different tumor growth over time. Chicks with the genotype Y1.2/Y1.2 had the lowest tumor
scores, and those with the genotype Y6/Y6 the highest. In this study MHC-Y genotypes had a
significant effect on tumor size, growth pattern, and chick mortality. The evidence from this
study, along with the conclusions of the 1996 Wakenell study, indicates that the MHC-Y does
influence immunological responses in the chicken.

Recombinational Hotspot - GC Rich Region Containing PO41 Repeat Sequence
Delany et al. (2009) reported the region between the MHC-B and the MHC-Y is GC rich
and may be half the size of microchromosome 16 in the chicken. Solinhac et al. (2010) showed
that this chromosomal region contains many copies of 41 base-pair tandem repeat called PO41.
The repeat region has 63% GC content, and has been found to be orthologous to a region found
in the turkey separating the MHC-B and MHC-Y. These repeated PO41 sequences help to
explain the independent genetic segregation known to occur between the MHC-B and MHC-Y
regions in the chicken genome, due to this hot spot of recombination (Solinhac et al., 2010).
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MHC-Y Variability Is Naturally Higher Than That of MHC-B
A study of free-range broiler chickens developed in Argentina was done by (Iglesias et
al., 2003) to genotype the line for MHC-B and MHC-YF types. This line, called Camperos, was
maintained without any selection for MHC haplotypes since its origin. 51 DNA samples were
analyzed for BF, BL, BG and YF genotypes, using RFLP and SSCP molecular methods. Of the
51 samples, 28 BF genotypes were distinguished, 29 BL, 39 BG and 44 YF. In comparing only
the class I molecules in this study, BF versus YF, it was found that the MHC-Y with 44
genotypes has a higher level of natural diversity than the MHC-B, with only 29 genotypes in the
Camperos line.

Copy Number Variation
Sources of genomic and genetic structural variation include; deletions, duplications,
inversions, single nucleotide polymorphisms (SNPs), variable number of tandem repeats
(VNTRs), and either the presence or absence of transposable elements. The widespread presence
of copy number variations (CNV) in normal individual genomes recently has been shown to be a
major form of genetic variability as well, possibly having influence on phenotypic variation such
as resistance and susceptibility to disease. Many immune system genes are multigene families
with CNV due to selection for pathogen response. (Salomonsen et al., 2014)
It has been known for some time through cytogenetic observations that the human
genome contained large duplications and deletions, but their frequency was thought to be low,
and most likely related to genetic disorders. Technological advancements have allowed
researchers to assess entire genomes, instead of being limited to specific loci. Two groups
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independently described that CNVs were widespread in the genomes of healthy individuals in
2004 (Freeman et al., 2006).
One of the first studies that describing the presence of CNVs in humans was done by
Iafrate et al. in 2004 using a technique called array-based comparative genomic hybridization
(aCGH). In this study more than 200 loci were identified to contain genetic imbalances among
39 healthy individuals.
Another researcher, Sebat et al. (2004) amplified BglII fragments from the genomes of
20 individuals, and hybridized the DNA to a microarray platform. 76 CNVs were identified in
this study.
In these two initial studies very little overlap between the different CNVs occurred,
indicating that possibly both studies underestimate the true number of CNVs found in the human
genome.
A third study by Tuzun et al. in 2005 compared two human genomes constructed in
different ways. The first genome was from the reference human genome sequence (NCBI, build
35), 67% of which originated from the RPCI-11 BAC library of a single anonymous male. The
second library came from fosmid clones of an anonymous North American female of European
decent. Fosmid clones are ~40kb. The researchers of the study reasoned that the clones should
like up on the reference sequence at 40kb spacing. Any deviation from this alignment would
indicate the presence of CNVs at the locus. Using this criterion, 241 CNVs were identified, 80%
of which had not been previously identified in the two earlier studies, indicating the widespread
prevalence of CNVs throughout the human genome (Freeman et al., 2006).
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In Angus cattle differences in multiple CNVs indicated resistance or susceptibility to
gastrointestinal nematodes (Hou et al., 2012). Humans with a low copy number of CCL3L1
have been found to be more susceptible to HIV (Gonzalez et al., 2005).
In this study copy number variation was analyzed in several chicken lines in three distinct
locations.

CHAPTER 2
CHARACTERIZATION OF THE CHICKEN MHC-Y SYSTEM USING SOUTHERN BLOT
ANALYSIS

Introduction
MHC-Y haplotypes have been found to play a role in chicken immunity. It is unknown
how many class I genes exist in the Y region and to what extent they influence disease
responses or other traits. The objective of this study was to use Southern Blot Analysis to
distinguish and analyze MHC-Y haplotypes in three different chicken populations. In the NIU
chicken line, five MHC-Y haplotypes were originally identified. Reanalysis after several years
revealed that additional novel MHC-Y haplotypes were present in the line. The DNA from the
Arkansas Progressor (AP) and Arkansas Regressor (AR) line were analyzed, (Nicolas B.
Anthony, University of Arkansas, Fayetteville, AR, USA) as well as the DNA of eight lines
from a commercial breeder (The name of the breeder is not mentioned due to a confidentiality
agreement). Both the NIU and Arkansas stocks have been closed for many years with the
Arkansas stocks having been selected for progression or regression of Rous sarcomas. The
commercial lines have been selected for production traits.
Extensive variation was found in the number of novel MHC-Y haplotypes in the three
different chicken populations, as well as variation in the number of bands per haplotype.
Understanding the diversity of the MHC-Y will help elucidate the function of this locus as well
as aid in understanding how it recombines and evolves in order to assist the chicken in its
ongoing battle against pathogens.
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Materials and Methods
Genetic material used in this study came from the NIU chicken line in DeKalb, IL,
which is a derivative of Wisconsin Line 3, the University of Arkansas poultry research farm,
Fayetteville, AR, and a commercial poultry breeding facility in Iowa.

DNA
Blood samples (1mL) were collected from the brachial veins of the chickens using
disposable syringes with the plunger dipped in powdered heparin as anticoagulant. Samples
were transferred to sterile 10mL tubes containing approximately 4mL of sodium citrate solution
(0.07M Na3C6H5O7.2H2O [NaCitrate] and 0.07M NaCl; pH8.0). The red blood cells were
allowed to settle to the bottom of the tube overnight. 50uL of the settled RBCs were added to
lysis buffer. DNA was isolated using a simple salting out procedure (S. A. Miller, Dykes, &
Polesky, 1988).

RFLP Procedure
The MHC-Y haplotypes were identified using a RFLP technique modified from (W. Elwood
Briles et al., 1993). Plasmids containing a 626 bp YF specific probe insert 163/164f, and a plate
of XL1-Blue, E. coli cells (Agilent, Santa Clara, CA, USA) were provided by Marcia Miller
(Beckman Research Institute, City of Hope, Duarte, CA, USA). A colony of XL1-Blue cells were
inoculated into 100mL of Luria-Bertaini (LB) broth and grown in a 37°C shaker for 3 hours.
Competent cells were made by treating the bacterial cells with cold calcium chloride solution
overnight. Competent cells (200uL) were inoculated with 2uL of plasmid DNA and put on ice for
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30 minutes. They were put in a shaking water bath at 42°C for 30 sec, then briefly iced for 20 sec.
One mL of SOC medium (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM
MgCl2, 10 mM MgSO4, 20 mM glucose) was added to the tube and the cells were returned to a
37°C shaking water bath and allowed to multiply for two hours. LB ampicillin (50ug/mL) agar
plates were prepared and cells were plated and incubated at 37°C for 24 hours. E. coli cells that
did not contain the plasmid with the 163/164f probe insert did not form colonies in the presence
of ampicillin. One colony of cells containing the 163/164f probe insert was selected with a sterile
toothpick and inoculated into 500mL of LB plus ampicillin broth and grown overnight in a 37°C
shaker.
Plasmids were purified from cells using a miniprep procedure. Cells were centrifuged at
2,500 rpm for 15 minutes. The broth was poured off and cells were re-suspended in 100mL of
solution 1 (50mM glucose, 25mM Tris-Cl, pH 8.0, and 10mM EDTA, pH 8.0) to increase the
osmotic pressure of the cells. After five minutes a 0.2 N sodium hydroxide/ 1% SDS solution was
added to lyse the cells and denature the DNA. After five minutes an ice-cold solution of 5M acetic
acid and 3M potassium acetate was added to precipitate and re-nature the DNA on ice for five
minutes. The solution was transferred to a 1.5mL microfuge tube and 500uL of
phenol/chloroform/isoamyl alcohol (25:24:1 v/v) was added. The tube was then vortexed, and
centrifuged in a microcentrifuge for five minutes at 5,000 RPM. The top layer of solution
containing the DNA was transferred to another tube, and one mL 95% ethanol was added. The
tube was then centrifuged at 5,000 RPM for 5 minutes and the ethanol was poured off, leaving a
pellet of precipitated DNA in the tube. The DNA pellet was then washed with 70% ethanol to
remove any salts. The tube was centrifuged for five more minutes at 5,000 RPM, and the ethanol
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was removed. The tube containing the remaining plasmid DNA was allowed to dry inverted for
one hour at room temperature. The plasmid was resuspended in 50uL of TE buffer (10mM TrisHCl, 1mM EDTA; pH 8.0) containing RNase (20ug/ml). The plasmid containing the 163/164f
probe insert was then digested with the restriction enzyme Xba I for four hours in a 37°C water
bath. The digested DNA was then precipitated using 5ul of 3M sodium acetate and 110mL of 100%
ethanol, centrifuged, and the DNA pellet was allowed to dry at room temperature as described
above. The DNA was resuspended in 20uL of TE buffer (10mM Tris-HCl, 1mM EDTA; pH 8.0)
and electrophoretically separated on a 0.8% 1X agarose gel containing 0.2ug/mL ethidium
bromide overnight at 30 volts. The plasmid and insert were visualized on a UV Transilluminator.
The 163/164f insert was cut from the gel using a sterile razor blade. The gel containing the insert
was centrifuged through a barrier pipet tip. The insert was then precipitated from the solution
using 5ul of 3M sodium acetate and 110uL 100% ethanol. The DNA pellet was allowed to dry at
room temperature for one hour. 12mL of TE buffer (10mM Tris-HCl, 1mM EDTA; pH 8.0) was
added to the isolated 163/164f probe insert.

Labeling of 163/164f Probe
The Rediprime II random prime labeling system (GE Healthcare, Pittsburgh, PA, USA) and
P-32 (MP Biomedicals, Santa Ana, California, USA) was used to radioactively label the 163/164f
YF probe. Forty-five microliters of probe was denatured for five minutes in a thermocycler at
95°C then added to a Rediprime reaction tube. Five microliters of 0.02 N P-32 were added to the
reaction tube and mixed well. The tube was placed in a 37°C water bath for 30 minutes. To stop
the labeling reaction 5uL of 0.2M EDTA; pH 8.0, was added and the reaction tube was placed on
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ice for five minutes. Unlabeled oligonucleotide was removed using Amicon Ultra 30 micron
columns (EMD Millipore, Billerica MA, USA). A small sample of labeled probe was then
measured for radioactive activity using a Beckman Coulter LS 1701 scintillation counter
(Beckman Coulter, Pasadena, CA, USA). The remainder of the probe was frozen until further use.

Southern Blots
Whole blood samples were obtained by collecting approximately 100uL of blood from the
brachial vein into a tube containing 2.5mL of sodium citrate solution (0.07M Na3C6H5O7.2H2O
[NaCitrate] and 0.07M NaCl; pH8.0). High quality genomic DNA was extracted from whole
blood with a modified protocol using proteinase K and a simple salting-out method (Miller et al.,
1988). The DNA was analyzed for quantity and quality using a Nanodrop 1000 spectrophotometer
(Thermo-Fisher Scientific, Waltham, MA, USA). For each DNA sample, 10ug of DNA was
digested in a 50uL restriction enzyme reaction using 2uL of restriction enzyme Bgl I, and digested
overnight in a 37°C water bath. The digested DNA samples were electrophoretically separated on
a 0.8% agarose gel containing 0.2ug/mL ethidium bromide for 22 hr at 30 volts. Gels images were
obtained using Kodak Gel Logic 200 Imaging System. The gels were then denatured by washing
in 0.35 N HCl for 10 minutes, then with 1.5 M NaCl/0.5 N NaOH two times for 15 minutes. Once
the DNA in the gel was denatured, the gel was neutralized in two 15 minutes washes of 1M
Tris/1.5 M NaCl pH7.4. The DNA was then transferred to Hybond-N+ nylon membrane in 10x
SSC by Southern blot technique overnight. The DNA was permanently crosslinked to the
membrane using a UV Crosslinker (Agilent, Santa Clara, CA, USA).
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To hybridize the membranes with the radiolabeled probe, the membranes were placed in
pre-hybridizing solution containing 50% formamide, 5x SSPE, 5x Denhardt’s solution 0.5% SDS,
salmon sperm DNA, and poly A oligonucleotides at 42°C for four hours in a hybridization oven.
The P-32 labeled probe was denatured in a thermocycler for five minutes at 95°C and then
combined with 25mL of hybridization solution (50% formamide, 5x SSPE, 1x Denhardt’s, 0.1%
SDS, 200ug/mL salmon sperm DNA, 100ug/mL poly A oligonucleotides and 5% Dextran Sulfate)
and allowed to hybridize overnight at 42°C. The membranes were then washed with a low
stringency wash solution containing 1x SSC and 0.1% SDS for 30 minutes three times. The
membranes were then washed with a high stringency wash of 0.1x SSC and 0.1% SDS for 30
minutes three times. The membranes were then wrapped with plastic wrap and put into
phosphoimager cassettes (Molecular Dynamics, Sunnyvale, CA, USA) containing phosphor
screens. The membranes were left in the cassettes three to five days to maximize the resolution of
bands. The phosphor screens were scanned on a PhosphorImager (Amersham Biosciences, Little
Chalfont, UK) with images saved as jpegs. The images were then examined, and MHC-Y
haplotypes were determined for all lines, using previous haplotype determinations from Southern
blots produced by the Miller lab on the NIU line as a guide (personal communication).

Results
In the original analysis of the NIU stock, five MHC-Y haplotypes were found to be
segregating. The banding patterns on the Southern blots were compared to a previous MHC-Y
typing of the NIU line (Marcia Miller, Beckman Research Institute, City of Hope, Duarte, CA,
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USA). The haplotypes were matched to the previously assigned haplotype patterns, and
designated Y1, Y2, Y3, Y5 and 6 (Figure 5).

NIU MHC-Y Haplotypes 2002

Figure 5. Identifying MHC-Y haplotypes in the NIU stock in 2002. Genotypes are designated at
the bottom of each lane. Haplotype Y1/Y1 in the NIU line was found to have two fragments,
Y2/Y2 has 3 fragments, Y3/Y3 has 5 fragments, Y5/Y5 has 6 fragments and Y6/Y6 has 10
fragments.

33

Figure 6. MHC-Y haplotypes in NIU stock 2007. The Y1, Y3 and Y6 haplotypes were found the
NIU line in 2007. A type similar to Y2 was found, but the lowest fragment is a smaller size.
Also a similar type to Y5 was found, but the haplotype is missing a fragment around 6Kb. Three
haplotypes were found in the 2007 stock that were not observed in the 2002 MHC-Y typing.
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Figure 7. The Arkansas lines appear to have unique haplotypes when compared to the NIU
MHC-Y haplotypes. The fragments have a broader size range, and the number of fragments per
haplotype exceeds that of the NIU line, with Y5 in the Arkansas line appearing to have 13-15
fragments in its haplotype.
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Figure 8. Line one of the commercial birds has two MHC-Y haplotypes, with the first type
having 3 fragments and the second haplotype having 6 fragments.
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Figure 9. Line 2 of the commercial line has 4 MHC-Y haplotypes. The first two haplotypes are
simple with two fragments each. Y3 and Y4 are more complicated with Y3 having 5 fragments
and Y4 having 6 fragments.
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Figure 10. Line 11 of the commercial line has 2 simple MHC-Y haplotypes. Y1 in this line is
very similar to Y1 in the commercial Line 2. Y2 in Line 11 has a unique pattern.
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Figure 11. Line 13 of the commercial lines has 2 complex MHC-Y haplotypes. Y1 in this line
has 8 fragments, and Y2 consists of 6-8 fragments considering that the two lower bands in Y2
are possibly double bands.
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Figure 12. Line 16 of the commercial lines has 4 MHC-Y haplotypes. Y1 is similar to the Y1
haplotype in Line 2 and Line 11 and the Y3 haplotype in Line 16 is similar to Line 11 but the
upper fragment is smaller than that of Line 11.
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Figure 13. Line 19 of the commercial lines had two previously well-defined MHC-Y haplotypes
known as Y1 and Y5 (Marcia Miller, pers. comm.), Y1 being the simpler haplotype with 4
fragments and Y5 having 7 fragments. In the latest typing of this line, a new haplotype
containing 5 fragments was prevalent in the population.
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Figure 14. Line 22 of the commercial lines has 2 MHC-Y haplotypes, both fairly complex. Y1
has 8 fragments and Y2 has 7 fragments.
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Figure 15. Line 25 of the commercial lines has 4 MHC-Y haplotypes. Y2 in Line 25 is similar to
Y3 in Line 16. The other three haplotypes seem unique to this line.
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The above figures demonstrate the variation in the MHC-Y in different lines. The chickens
from the NIU line have different RFLP patterns and numbers of fragments per haplotype,
compared to the Arkansas lines and the commercial lines. Some of the commercial lines may
share certain haplotypes, due to the fact that they would have originated from the same stock
many generations ago, but each line contains at least one or more unique MHC-Y haplotype.

Recombination in the MHC-Y Can Be Directly Observed in Southern Blots
It is not surprising that the MHC-Y region genes recombine considering its location on
microchromosome 16 in the chicken genome. The MHC-Y is located is next to a GC rich region
with high recombination rates containing PO41 repeated elements (Solinhac et al., 2010). On the
other side of this region of high recombination is the MHC-B system. Briles has observed,
collected and maintained several B haplotypes that have recombined over many years
(unpublished observation). Recently the recombination rate in the MHC-B region has been found
to be about 1 per 150 birds (Janet Fulton, personal communication.). Based on its location, the
MHC-Y region would likely exhibit a similar or greater recombination rate.

Evidence of Recombination in the NIU Line
There is evidence that the MHC-Y locus recombines readily, as seen in the NIU Line
typings. The MHC-Y typing from 2002 has five haplotypes in the population. Five years later
progeny of the same NIU Line was typed for MHC-Y, and differences in the RFLP patterns
were observed. In five years unique MHC-Y haplotypes were formed in the closed line (Figures
5 & 6). It can be seen that some of the haplotypes from the 2002 typing remain, but other
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haplotypes have small differences, and unique haplotypes not seen in 2002 are prevalent in the
2007 line.
It was also noted that in the commercial Line 19 (Figure 13) that the line had be
previously known to have only two MHC-Y haplotypes, but in a subsequent typing a new
haplotype was found to be prevalent in the line.
A recombination event that occurred in family 619 of the NIU Line is illustrated (Figure
16). The mating between Sire 619 and Dam E619 created a new MHC-Y haplotype in one
chickprogeny.

Copy Number Variation Can Be Observed in Southern blots
The Southern blots indicate that there is considerable variation in the number of
fragments in an MHC-Y haplotype. The fragments in the homozygous genotypes indicate the
number of chicken MHC-Y class I genes or pseudogenes in each haplotype. Some MHC-Y
haplotypes consist only of two or three bands, while others have as many as 14 bands, as seen in
the Arkansas line.

Future Research
In future MHC-Y studies, a SNP panel can be created using published genome
sequences, and birds can be genotyped without the use of radioactivity or equipment that is not
readily available. Through a combination of SNP typing and qPCR to look for copy number, a
comprehensive system for identifying MHC-Y haplotypes could be developed, creating a more
reliable method for typing the MHC-Y.
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Figure 16. A recombination event is illustrated in the typing of NIU family 619 .
Sire 619 in the above figure has the genotype Y5/Y6. Dam C619 is Y5/Y5. The lone
chickprogeny is to the right of the dam is also Y5/Y5. The same sire was mated to dam E619
with the Y3/Y5 genotype. Their progeny, listed to her right, should be either Y6/Y3, Y6/Y5 or
Y5/Y5. One progeny seems to be Y5/Y5 but he has an extra band in its genotype as indicated by
the circle, creating a new haplotype.

CHAPTER 3
EXAMINING ALLELIC COPY NUMBER VARIATION IN THE CHICKEN MHC-Y USING
PCR-DGGE

Introduction
A technique called Polymerase Chain Reaction – Denaturing Gradient Gel
Electrophoresis (PCR-DGGE) was used in order to confirm MHC-Y copy number variation that
was observed on Southern Blots. This technique separates PCR generated products based on
sequence differences due to differential denaturing characteristics of the DNA.
During DGGE, double stranded PCR products are run on a denaturing polyacrlamide
gel. As the DNA strands migrate down the gel they encounter increasingly higher
concentrations of chemical denaturant. The weaker melting domains of the PCR will begin to
denature as they reach a threshold denaturant concentration. Differing sequences of DNA will
denature at different denaturant concentrations resulting in a pattern of bands. Each band
represents a different gene copy, and gene sequence in the DNA.
The hope in using the PCR-DGGE technique was to attempt to find an accurate way to
genotype chickens for MHC-Y alleles. Additionally, this technique would indicate multiple
gene copies of the MHC-Y genes.
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Materials and Methods
Primer Design
For the DGGE technique to work, a GC-rich sequence (GC-clamp) must be added to
one-end of one of the PCR primers, in order to produce a product that will not completely
denature in the denaturing gel. As DNA molecules migrate down the gel and become partially
denatured, their mobility decreases. However, we need to avoid allowing the double-stranded
DNA molecules to become single stranded.
A software program developed at MIT called MELT94
(http://web.mit.edu/osp/www/melt.html) was used to design the DGGE primers to determine
which primer of each pair should have a GC clamp on it. The melting behavior of MHC-Y
exons 2, 3, 4, and 5 were analyzed. The profile of the primer set up having the most uniform
(flat) melting domain was chosen for each exon, the determination of where the GC clamp
should go was made, and PCR primers were designed. The best melting profile for all for exon
primer pairs turned out to have the GC clamp attached the reverse primer.
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Table 1. DGGE Primers - Class I MHC- Y
Exon
2
YF75
2
YF76
w/GC
2
3
4
5

Forward
GTGGACGACAAAATCTTCGGTA
Reverse

Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

CGCCCGCCGCGCCCCGCGCCCGGCCCGCCCGCTTTGTTGTAGCGTTCCGGCAGCC
TCGCACTCCCTGCGCTACTTC
CGCCCGCCGCGCCCCGCGCCCGGCCCGCCCGCTTTGTTGTAGCGTTCCGGCAGCC
GGTCTCACACGATGCAGATG
GCCGCCGGGCGCCGCCCGCGCCGCCCGGGGGTCCCATGCTCCAGGTATCTC
AGTGCAGCCCGAGGTGCGAGTGTGG
GCCGCCGGGCGCCGCCCGCGCCGCCCGGGAGTGCAGCCCGAGGTGCGAGTGTGG
AGAGCCGCAGCCCAACCTGATT
GCCGCCGGGCGCCGCCCGCGCCGCCCGGGCCTGACTTGCTCTTCCACACCACCA

The YF75 and YF76 primers were designed by Marcia Miller (Beckman Research Institute, City
of Hope, Duarte, CA, USA) and correspond to the 1 binding region of the MHC-Y molecule in
exon 2. This binding region is of interest because of its similarity to the human HLA-A2
protien region, except that it lacks a H1 helical region that is found in classical MHC molecules
(Afanassieff et al., 2001). Other primer pairs correspond to the entire exons of the MHC-Y
molecule. The GC clamps are in bold.
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The DGGE equipment (gel assembly, gradient maker, DGGE tank) that was used was
purchased from C.B.S. Scientific, Inc. (San Diego, CA, USA). The protocol used was adapted
from the Von Sigler lab at the University of Toledo.
(http://www.eeescience.utoledo.edu/Faculty/Sigler/Von_Sigler/LEPR_Protocols_files/DGGE.p
df)

Building Gel Assembly
Spacers and combs were washed thoroughly with Neutrad liquid cleaner (VWR, Radnor,
PA, USA) and then cleaned well with 95% Ethanol. Glass plates were cleaned in a 50% Nitric
Acid bath, rinsed with water, then cleaned with 95% Ethanol.
The gel sandwich was assembled by placing the large glass plate on a square piece of
polystyrene to protect it from scratching on the counter. The gel wrap gasket was stretched
along the bottom of the large glass plate to prevent the gel from leaking. The small glass plate
was placed on top of the large plate, and a 1 mm spacer was placed along each edge of the plate
assembly. Clamps were placed along the bottom and sides of the glass plates to hold them
together. Two clamps on the bottom acted as legs to hold the plates vertical for pouring the gel.
The gradient maker was placed on a platform about two feet above the lab bench and
secured in place on top of a stir plate with a ring stand. The lever in the middle that combines
the two gradients was closed as well as the other shut off valves along the delivery tube. The
following table was used to determine the appropriate composition of the denaturing gradient
gel.

50

Table 2. DGGE gel composition.
Reagent
Water
40%
acrylamide:bis
(37:1)
50X TAE buffer
Urea (g)
Formamide
Glycerol

Final
Conc.
8%

1X

2%

Cap

Milliliters of Reagent for Denaturant Conc.
40%
45%
50%
55%
60%
65%

70%

3.6
1.3

7.5
3.0

7.0
3.0

6.5
3.0

6.0
3.0

5.0
3.0

5.0
3.0

4.5
3.0

0.1
0
0
0

0.3
2.5
2.4
0.3

0.3
2.8
2.7
0.3

0.3
3.1
3.0
0.3

0.3
3.4
3.3
0.3

0.3
3.7
3.6
0.3

0.3
4.0
3.9
0.3

0.3
4.3
4.2
0.3

The composition of the gel varies in the amount of water, urea, and formamide, depending on
the percentage of denaturation.

Table 3. Volume of polymerization reagents for denaturing gels.
Polymerizing Reagent

Low and High gel solutions

Cap

10% APS

81uL

40uL

TEMED

4.5 uL

2.5uL
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Two solutions of 15mL volume each were made; a “low” denaturant concentration
solution, and a “high” denaturant concentration solution, according to Table 2. The two volumes
were mixed thoroughly to dissolve the urea.
The polymerization solutions, 81uL 10% ammonium persulfate (APS) and 4.5uL
Tetramethylethylenediamine (TEMED), were added into each of the high and low gel solutions
immediately before pouring the gel and swirled gently to mix.
The high and low solutions were poured into the gradient maker. The low denaturant was
poured in the chamber with the connecting channel, and the high denaturant in the chamber with
the outlet channel. Magnetic fleas were placed into each column of the gradient maker and the
stir plate was turned on. An 18 gauge hypodermic needle was attached to the end of the delivery
tube and inserted between the two glass plates and taped into place. The gel was poured by
opening the valve on the gradient maker to combine the two gel concentrations, then opening
the valve on the delivery tube. After the gel was poured, a layer of 95% ethanol was added to
smooth the top boundary of the gel.
The gel was allowed to polymerize for 1-3 hours. The ethanol was removed from the top
of the gel by inverting the glass plates and using Kimwipes (Kimberly-Clark, Romeoville, IL,
USA) to wick the ethanol from between the glass plates. 3mL of “cap” solution (Table 3) was
then added to the top of the polymerized gel with a transfer pipepette. The comb was carefully
placed between the glass plates and lowered into the cap solution. The gel was then allowed
polymerize at least two hours to overnight.
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DGGE
The buffer chamber of the DGGE tank was filled with 0.04M Tris-Acetate and 0.001M
EDTA (1X TAE) buffer and preheated to 65°C. When the temperature in the tank reached 50°C,
the gel was attached to the core assembly on the front side. Glass plates without a gel were
attached to the back side of the core assembly in order to form an inner buffer chamber on the
assembly. The core assembly was placed in the buffer tank and the top reservoir was filled with
1x TAE buffer. The tank was allow to continue heating until the buffer reached 65°C. The comb
was removed from the gel and each well was flushed with buffer solution. 6X blue/orange
loading dye (Promega, Madison, WI, USA) was added to the PCR products to achieve a 1X
concentration. The PCR products were then loaded into the wells of the polyacrylamide gel in
the DGGE tank. The gel was then run at 100 V for 16 hours (1600 V-h)
When electrophoresis was complete the apparatus was taken apart and the gel was
carefully transferred to a sheet of overhead transparency film (Staples, Framingham, MA, USA)
for transport. The wells were trimmed off with a razor blade and the gel was stained in 100mL
distilled water with 10mL ethidium bromide (10mg/mL) for 10 minutes, then rinsed in 200mL
distilled water for 5 minutes. An image of the gel was then taken using the Kodak Gel Logic
200 Imaging System (Eastman-Kodak Co., Rochester, NY, USA).
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Results
The DGGE technique was originally chosen to ascertain if this technique could be a
useful typing in determining MHC-Y haplotypes, as well as MHC-Y copy number. The MHC-Y
genotypes were known beforehand for each of the samples through RFLP typing.
The results of the DGGE using the first primer pair seemed like they may be promising
for using the DGGE technique as a genotyping tool.
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Figure 17. DGGE run on a 40-55% denaturing gel with Y75/Y76 primer pair. The first 8 samples
on the left were run for 16 hours at 150 Volts. The same 8 samples were run on the right for 10.5
hours at 150 Volts.

The different genotypes in Figure 17 did exhibit different banding patterns and variable
numbers of bands. The hope was that the banding patterns would be able to individual discern
haplotypes. In this gel one sample is heterozygous 1.1/5.1. It can be seen that this is a
combination of the patterns of the 1.1 homozygous genotype and the 5.1 homozygous genotype,
but the heterozygous pattern is not easily distinguishable from the 5.1 homozygous pattern.
Additional DGGE gels were run with the Y75/Y76 primer pair (Figure 18).
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Figure 18. The same 8 samples as the previous figure run on a DGGE gel with a 40-65%
denaturing gradient. The samples on the left were run for 12 hours at 150 V, the samples on the
right for 9 hours at 150 V. There seems to be less resolution in this gel and the heterozygous
1.1/5.1 genotype is still not discernable from the 5.1/5.1 genotype.
DGGE was performed multiple times changing the PCR samples, voltage and denaturing
gradient to find an optimal situation where MHC-Y haplotypes could be distinguished from one
another. Finally it was determined that this tool does not give as much resolution as the RFLP
technique, and will not be useful alone as a typing tool in distinguishing MHC-Y haplotypes.
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The DGGE technique can be used to show copy number variation. In an attempt to limit
the number of pseudogenes replicated in PCR samples. I decided to change the PCR primers to
include the entire exons of the MHC-Y molecule.

Figure 19. Exon 2 DGGE gel with a 45-70% denaturing gradient. This gel indicates sequence
and relative copy number variation, especially in the Y3 and Y5 haplotypes. Haplotypes Y1, Y2,
Y6 and Y1.1 all have very similar banding patterns. Because some haplotypes look alike using
the Exon 2 primers for typing with DGGE will not be useful.
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Figure 20. Exon 3 DGGE gel with a 45-70% denaturing gradient. This gel indicates relative
copy number varation and sequence variation for each haplotype due to the variable banding
patterns. Exon 3 is the most promising in distinguishing haplotypes using DGGE.
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Figure 21. Exon 4 primers on 40-70% denaturing gel .The primers for exon 4 produced smeared
bands when run on the DGGE gel. I was not able to find a gradient that gave distinct bands with
these primers. This primer pair for exon 4 was not useful for observing copy number variation or
for genotyping for MHC-Y.
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Figure 22. Exon 5 primers on 60-75% denaturing gel. Using primers for exon 5 I was not able to
produce a gel with distinct bands for genotyping. It can be seen on this gel that there is pattern
variation within the exon indicating copy number variation and sequence variation in the copies
of exon 5.
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Conclusion
The DGGE technique proved to be useful for illustrating relative copy number variation,
each band indicating a different copy of the exon, and sequence variation in the chicken MHCY. The exon 3 primers gave the most distinct banding patterns for each of the haplotypes, out of
all the primers that were tested. A lot of time was spent trying to optimize the gels so that the
exon 3 primer pair could be used as a typing tool for typing the MHC-Y. After many tries it was
determined to be too difficult to determine MHC-Y haplotypes using DGGE with any certainty.
Sometimes it was not possible to determine whether a genotype was homozygous or
heterozygous using the DGGE technique.
Perhaps with time, adjusting the gel denaturing concentrations, voltage and time run, the
DGGE technique could be used to determine MHC-Y haplotypes in a population.
At this point, it may be feasible to determine the MHC-Y genotypes of a family of chickens
provided that the genotypes of the parents were predetermined by RFLP, although, in using this
technique some recombination events would most likely be missed since DGGE is less sensitive
than RFLP.

CHAPTER 4
QUANTITATIVE REAL-TIME PCR

Copy Number Variations (CNV) have been found to have deleterious as well as
advantageous effects in genome functions, (see above). The chicken is an important agricultural
species, and knowledge of CNVs in the genome, especially the MHC will be important for
identifying relationships between copy number and disease phenotypes. It is difficult to tag
CNV using SNP techniques because sometimes copied segments are transposed into distant
genomic locations (Schrider & Hahn, 2010). In this study quantitative real-time PCR (qPCR) is
used for CNV analysis since it has been determined to be a fast and reliable method for
determining copy number (Fernandez-Jimenez et al., 2011).

Material and Methods
Primers were designed to produce an amplicon of around 300 base pairs in most
instances and have an annealing temperature around 60°C. Primer sequences were queried
against the GenBank database using BLASTn (Altschul et al., 1997) to determine if primers
might anneal to undesired regions of the genome. Positive and negative controls were run for
each reaction. DNA samples were serially diluted by 10X and PCR was performed in order to
determine the optimal concentration of DNA for qPCR. The concentration of 40ng/ul of DNA
was chosen because at this concentration genomic DNA did not appear on the gel and the
primers did not form non-specific bands or primer dimers as they did at higher concentrations.
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Table 4. Primers used in qPCR experiment.
Control
Exon 2
Exon 3
Exon 4
Exon 5
Exons 6-7
Exons 7-9

PCCA-F

GTGCACATAGAGCAAAAATGCAGACACACAGAGCC

PCCA-R

GCCTGGAGCAGTGGTGGCTGTT

E2-Q fwd

GGGTCGCACTCCCTGCGCTACTTCC

E2-Q rvs

TGTTGTAGCGTTCCGGCAGCCTG

E3-Q fwd

GGGTCTCACACGATGCAGATGATGTTTGGCTGTG

E3-Q rvs

TCCTTTTCAGCGCTGCCTTCCCATGCTCCA

E4-Q fwd

AGTGCAGCCCGAGGTGCGAGTGTGG

E4-Q rvs

CCACGCTGCCAGCTCACCCCATGAGAAG

E5-Q fwd

AGAGCCGCAGCCCAACCTGATT

E5-Q rvs

CCTGACTTGCTCTTCCACACCACCA

YFquantF1

CCCCCTTGGGAATGCCCATGTTCTG

YFquantR1

CCCTCCTGAGCCCCCGTTCCACAC

YFquantF2

TGCTCCATGCCCCATAGCGAGCACA

YFquantR2

TGGAAGGTTCACTTCCTGTGCGGGTGA

Quantitative real-time PCR was carried out using a Stratagene Mx3000P RT-PCR
system. A master mix was prepared with 1.25 µl of the forward and reverse primers at a
concentrations of 10 ng/ul each, 6.75 µl water, and 0.25 µl 100X dilution (1X) Reference dye R
4526 (Sigma-Aldrich, St. Louis, MO, USA).
Each individual reaction contained 9.5 µl of the master mix, 3 µl of template DNA and 12.5 µl
of SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich, St. Louis, MO, USA) for a final
volume of 25 µl.
Cycling conditions were as follows: denaturation (94C for 2 min), followed by 40
cycles of amplification (94C for 30 s, 60C for 30 s, 72C for 30 s), and final denaturation
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(72C for 1 min). Data were collected at the end of the annealing step. The cycle threshold (Ct)
for each sample was generated by the MxPro software (Agilent Technologies, Santa Clara, CA,
USA).
The Ct values for each sample correspond to the point at which the fluorescence crosses
the threshold. Fluorescence from SYBR green increases as double-stranded DNA accumulates
(Morrison, Weis, & Wittwer, 1998).
Subsequent to amplification, characterization of products was performed by melting
curve analysis (95C for 1 min, 55C for 30 s, 95C for 30 s). Fluorescence data were
continuously collected as the temperature ramped up from 55C to 95C. The dissociation
curve for each sample was generated by the MxPro software to determine the melting
temperature (Tm) of the reaction product(s) using the value –Rn´(T) (the first derivative of the
normalized fluorescence reading multiplied by –1).
A control gene was chosen to serve as a single copy reference. This gene would be
amplified along with the MHC-Y qPCR samples to compare the single copy gene to the variable
genes. The gene that was chosen was propionyl coenzyme A carboxylase (PCCA) because it
was shown to exist as a single copy in an analysis of the chicken genome assembly. PCCA was
used as a single copy control in a previous study to detect CNVs in the chicken genome (Wang,
Nahashon, Feaster, Bohannon-Stewart, & Adefope, 2010).
To analyze the qPCR results the comparative Ct method was used (Schmittgen & Livak,
2008). This method makes the assumption of equal primer efficiency and that both targets have
similar characteristics, and can calculate relative expression change.
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Results
Using the qPCR technique, primers that bind to the exons of the MHC-Y were used,
along with a single copy control gene PCCA. The primers that were used for PCCA produced a
small product of 60 base pairs (bp). Exon 2 primers produced a 254 bp product, Exon 3 primers
a 275 bp product, Exon 4 a 275 bp product, and Exon 5 a 106 bp product. The two primer pairs
that cover Exons 6-8 correspond to the 163/164f DNA probe used in the Southern blots. The
primers that bind to the first and second halves of the probe each produce a product of about 300
base pairs.
The PCCA control primers gave Ct values that resulted in a copy number higher than the
Y1/Y1 and Y2/Y2 genotypes in most cases, even though it has been used as a single copy
control in other studies. A possible explanation for this was the very short product produced by
the PCCA control, of 60 base pairs, allowed for greater amplification efficiency during the PCR
elongation step. The rest of the primer pairs produced products around 300 bp, except for exon 5
which had a 106 bp product. To correct for this problem in the future, primers in the PCCA
control gene should be made to amplify products of a more similar size to the rest of the
products in the test.
To normalize the data the Y2/Y2 genotype was chosen to be the single copy genotype
because according to the results, Y2/Y2 had the lowest copy number in exon 2 and most of the
exons. The Ct values of the Y2/Y2 genotype were averaged, and compared to the Ct values of
the other genotypes to determine copy number. The formula used to calculate relative copy
number was R= 2^(-Ct) (Schmittgen & Livak, 2008) where the average Ct value of Y2/Y2 was
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used as the comparison since it was the haplotype with the highest Ct values indicating the
lowest copy number. Haplotypes Y1/Y1, Y3/Y3, Y5/Y5 and Y6/Y6 were all compared to the
average of Y2/Y2. The difference between the experimental value and the control value were
calculated giving the Ct. That value was then plugged into the equation R= 2^(-Ct) to give
the relative copy number.
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Table 5. qPCR results for Exon 2

Bird.ID
(20)B414
71342

(14) A413
71123

Haplo
type

Rxn.ID

CT

Product

Y1

`113464
`113663
`122709
`122744
`122785

27.54
27.90
26.00
26.27
27.20

90.6
90.1
90.2
90.2
90.2

Y2

`113566
`113707
`122710
`122745
`122786

31.64
29.29
27.69
28.02
28.24

90.2
90.15
90.2
90.2
90.2

Average
of Y2 Cts

28.97

Relative
Copy
Number

Mean

Standard
Deviation

2.71
2.11
7.87
6.53
3.42

4.53

2.53

1.00
1.00
1.00
1.00
1.00

1.00

0.00

(31) D412
71117

Y3

`113568
`113709
`122711
`122746
`122787

26.57
27.18
25.69
25.87
26.12

90.75
90.6
90.15
90.7
90.7

5.30
3.47
9.75
8.61
7.24

6.88

2.52

(56) B621
44120 1108

Y5

`113573
`121413
`122712
`122747
`122788

26.89
26.98
26.19
26.97
26.6

90.6
90.65
90.85
90.85
90.85

4.25
3.99
6.90
4.02
5.19

4.87

1.24

(35) I608
44018 722-08

Y6

`113658
`121416
`122713
`122748
`122789

24.8
23.98
24.83
23.14
23.88

89.7
90.1
90.35
90.35
90.3

18.08
31.91
17.70
57.12
34.20

31.80

16.08
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Exon 2

Copy number relative to Y2

60.00

50.00

40.00

30.00

20.00

10.00

0.00
Y1

Y2

Y3

Y5

Y6

MHC-Y Haplotype

Figure 23. The results for Exon 2 qPCR are complementary to what can be seen on the Southern
blots as far as relative copy number is concerned. The Y1/Y1 and Y2/Y2 genotypes have the
lowest copy numbers and the Y6/Y6 genotype has the highest copy number. On the Southern
blots the Y5/Y5 genotype seemed to have more products than the Y3/Y3 genotype, whereas the
qPCR results indicate that the Y3/Y3 genotype has a higher copy number than Y5/Y5.
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Table 6. qPCR results for Exon 3

Bird.ID
(20)B414
71342

(14) A413
71123

Haplo
type

Rxn.ID

CT

Product

Y1

`113468
`113671
`122714
`122749
`122790

27.72
27.14
25.34
26.18
25.91

87.6
87.6
87.3
87.35
87.33

Y2

`113574
`113715
`122715
`122750
`122791

26.49
36.3
25.87
25.62
26.38

87.75
87.1
87.3
87.33
87.35

Average
of Y2 Cts

28.13

Relative
Copy
Number

Mean

Standard
Deviation

1.33
1.99
6.93
3.87
1.39

3.10

2.37

1.00
1.00
1.00
1.00
1.00

1.00

0.00

(31) D412
71117

Y3

`113576
`122751
`122792

23.46
22.28
23.01

87.15
87.3
87.3

25.49
57.76
34.82

39.36

16.61

(56) B621
44120 1108

Y5

`113581
`121423
`122717
`122752
`122793

25.28
25.83
24.65
24.29
24.62

87.1
86.6
86.75
86.75
86.7

7.22
4.93
11.17
14.34
11.41

9.81

3.72

(35) I608
44018 722-08

Y6

`113666
`121426
`122718
`122753
`122794

23.78
23.87
22.44
21.72
22.36

86.7
87.1
86.7
87.2
86.7

20.42
19.19
51.70
85.15
54.64

46.22

27.45

69

Exon 3
80.00

Copy number relative to Y2

70.00
60.00
50.00
40.00
30.00
20.00
10.00
0.00
Y1

Y2

Y3
MHC-Y Haplotype

Y5

Y6

Figure 24. This figure for Exon 3 has a similar pattern to that of Exon 2, showing that Y6/Y6
has the highest copy number followed by Y3/Y3, Y5/Y5, Y1/Y1 and Y2/Y2 with the fewest
gene copies. There are fewer replicates for the Y3/Y3 haplotype because of an instrument
breakdown during the run of this trial.
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Table 7. qPCR results for Exon 4

Bird.ID
(20)B414
71342

(14) A413
71123

Haplo
type

Rxn.ID

CT

Product

Y1

`113472
`113679
`122719
`122754
`122795

27.03
26.47
26.61
25.47
25.37

90.6
91.1
90.65
90.7
90.7

Y2

`113582
`113723
`122720
`122755
`122796

27.94
27.9
26.6
26.18
26.37

91.2
91.6
91.85
91.85
91.85

Averag
e of Y2
Cts

27.00

Relative
Copy
Number

Mean

Standard
Deviation

0.98
1.44
1.31
2.88
3.09

1.94

0.97

1.00
1.00
1.00
1.00
1.00

1.00

0.00

(31) D412
71117

Y3

`113584
`113725
`122721
`122756
`122797

23.38
23.97
23.73
22.24
22.42

91.7
91.65
91.3
91.85
91.83

12.28
8.16
9.63
27.06
23.88

16.20

8.66

(56) B621
44120 1108

Y5

`113589
`121433
`122722
`122757
`122798

25.13
24.57
24.17
23.87
24.19

91.1
91.1
91.3
91.3
91.28

3.65
5.38
7.10
8.74
7.00

6.38

1.93

(35) I608
44018 722-08

Y6

`113674
`121436
`122723
`122758
`122799

25.78
23.42
23.29
22.13
22.13

90.15
91.6
91.33
91.25
91.25

2.33
11.94
13.07
29.20
29.20

17.15

11.77
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Exon 4
Copy number relative to Y2

35.00
30.00
25.00
20.00
15.00
10.00
5.00
0.00
Y1

Y2

Y3

Y5

Y6

MHC-Y Haplotype

Figure 25. This figure for exon 4 follows the pattern of exons 2 and 3, although the Y6/Y6
genotype appears to have half as many copies as it did in exons 2 and 3.
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Table 8. qPCR results for Exon 5

Bird.ID
(20)B414
71342

(14) A413
71123

Haplo
type

Rxn.ID

CT

Product

Y1

`113947
`122689
`122724
`122759
`122800

27.03
26.68
26.55
26.61
26.33

88.8
88.25
88.22
88.83
87.75

Y2

`113951
`122690
`122725
`122760
`122801

24.42
24.97
24.31
24.23
25.09

87.7
87.3
87.75
87.7
87.2

Average
of Y2 Cts

24.60

Relative
Copy
Number

Mean

Standard
Deviation

0.19
0.24
0.26
0.25
0.30

0.25

0.04

1.00
1.00
1.00
1.00
1.00

1.00

0.00

(31) D412
71117

Y3

`113953
`122691
`122726
`122761
`122802

21.15
21.53
21.71
22.15
20.96

87.8
87.8
87.75
87.7
87.7

10.96
8.42
7.43
5.48
12.50

8.96

2.80

(56) B621
44120 1108

Y5

`113958
`122692
`122727
`122762
`122803

22.09
21.98
22.21
21.68
22.2

87.75
87.7
87.7
87.7
87.7

5.71
6.16
5.26
7.59
5.29

6.00

0.96

(35) I608
44018 722-08

Y6

`113961
`122693
`122728
`122763
`122804

21.23
21.07
20.72
20.6
21.09

87.8
87.85
87.83
87.83
87.83

10.37
11.58
14.76
16.04
11.42

12.84

2.43
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Exon 5
Copy number relative to Y2

18.00
16.00
14.00
12.00
10.00
8.00
6.00
4.00
2.00
0.00
Y1

Y2

Y3

Y5

Y6

MHC-Y Haplotype

Figure 26. Exon 5 copy numbers look similar to exon 4, except that the Y2/Y2 genotype
has slightly more copies than the Y1/Y1 genotype.

QPCR was performed by making primers corresponding to the 163/164f DNA probe
used in the Southern blots. The probe was approximately 600 bp, so two primer pairs were
designed to amplify products so that each corresponded to half of the probe.
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Table 9. qPCR results for Exon for 1st half of Probe.

Bird.ID
(20)B414
71342

(14) A413
71123

Haplo
type

Rxn.ID

CT

Product

Y1

`113456
`113647
`122729
`122764
`122805

28.15
27.38
26.19
25.09
24.88

91.1
91.1
90.83
90.83
90.83

Y2

`113550
`113691
`122730
`122765
`122806

35.95
30.24
27.45
27.13
27.92

91.2
90.65
90.8
90.8
90.83

Average
of Y2 Cts

29.74

Relative
Copy
Number

Mean

Standard
Deviation

3.01
5.13
11.70
25.07
29.00

14.78

11.72

1.00
1.00
1.00
1.00
1.00

1.00

0.00

(31) D412
71117

Y3

`113552
`113693
`122731
`122766
`122807

25.09
25.39
29.93
24.29
23.19

90.75
90.6
90.25
90.3
90.3

25.07
20.36
0.88
43.65
93.57

36.71

35.24

(56) B621
44120 11-08

Y5

`113557
`121393
`122732
`122767
`122808

27.64
26.66
25.57
24.5
24.83

90.6
90.1
90.2
90.2
90.22

4.28
8.44
17.98
37.74
30.02

19.69
14.14

14.41

(35) I608
44018 7-22-08

Y6

`113642
`121396
`122733
`122768
`122809

27.42
25.2
24.65
23.68
23.77

90.15
90.1
90.2
90.2
90.2

4.99
23.23
34.01
66.63
62.60

38.29

26.21
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Probe 1st Half
80.00

Copy number relative to Y2

70.00
60.00
50.00
40.00
30.00
20.00
10.00
0.00
1

2

3

4

MHC-Y Haplotype

Figure 27. Copy number variation in 1st half of probe 163/164f.
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Table 10. qPCR results for Exon for 2nd half of Probe.

Bird.ID
(20)B414 71342

Haplotype
Y1

Rxn.ID
`113460
`113655
`122734
`122769
`122810

CT
31.81
32.43
29.19
28.78
29.4

Product
91.15
90.6
90.7
90.7
90.7

Y2

`113558
`113699
`122735
`122770
`122811

31.99
31.71
28.44
28.03
29.1

90.7
90.15
90.65
90.7
90.7

Average
of Y2
Cts

29.854

Relative
Copy
Number
0.26
0.17
1.58
2.11
1.37

Standard
Deviation
1.10
0.85

1.00
1.00
1.00
1.00
1.00

1.00
0.00

(31) D412 71117

Y3

`113560
`113701
`122736
`122771
`122812

25.95
25.92
24.48
23.57
24.63

90.25
90.15
90.35
90.35
90.35

14.97
15.28
41.47
77.92
37.37

37.40
25.74

(56) B621 44120 1108

Y5

`113565
`121403
`122737
`122772
`122813

27.8
27.26
26.76
27.33
25.98

90.1
90.1
89.83
89.85
89.8

4.15
6.04
8.54
5.75
14.66

7.83
4.13

(35) I608 44018 722-08

Y6

`113650
`121406
`122738
`122773
`122814

25.22
27.53
24.15
23.4
23.33

90.15
90.1
90.3
90.3
89.8

24.83
5.01
52.13
87.67
92.03

52.33
38.15
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Copy number relative to Y2

Probe 2nd Half

100.00
90.00
80.00
70.00
60.00
50.00
40.00
30.00
20.00
10.00
0.00
Y1

Y2

Y3

Y5

Y6

MHC-Y Haplotype

Figure 28. Copy number variation in 2nd half of probe 163/164f. The results of the probe qPCR
show similar patterns, which correspond to what is seen in the Southern blots.
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Conclusion
These results illustrate that certain MHC-Y haplotypes are found to have more gene
copies in the chicken genome than others. The results are largely interpreted as indicating copy
number of mhc loci. An alternative interpretation is that the results here indicate multiple alleles
at a single locus.
The qPCR was done in quintuplicate for each MHC-Y haplotype. In the middle of
conducting this experiment the qPCR machine that was giving extremely variable results. It was
determined that the machine was failing, was subsequently repaired. This may be part of the
reason that some of the Ct values vary widely for certain reactions. Another way to limit the
variation seen in this experiment may be to use primers that produce shorter products. The
primers used for Exon 5 produced a product of 106 base pairs. Exon 5 results showed less
variability in the standard deviations than the other exons. All other primer pairs produced
products around 300 base pairs, and had Ct values that varied more wildly.
Even though the standard deviations of the qPCR reactions were wide ranging, looking
at the overall picture, it can be seen that the results for each haplotype are fairly consistent. The
Y1 and Y2 haplotypes have the lowest gene copy number with Y2 most likely having the fewest
copies, while Y3 and Y6 are found to have the highest copy numbers in the MHC-Y, and the Y5
haplotype has a copy number somewhere in between Y1 and Y6. These results are consistent
with the results found with the Southern blot studies, with the exception that the Y5/Y5 in the
Southern blots seemed to have more bands than the Y3/Y3 genotype.

CHAPTER 5

SYNTHESIS

In Chapter 2, I provided an initial characterization of MHC-Y haplotypes in the chicken.
MHC-Y diversity among different populations was compared using Southern Blots analysis. The
results of this study indicate the MHC-Y is extremely variable within and among chicken lines.
The initial genotyping of the NIU Line in 2002 indicated that there were 5 MHC-Y haplotypes.
Subsequent MHC-Y typing in 2007 showed that the same closed line had as many as 8 MHC-Y
haplotypes, with haplotypes being similar to the 2002 types but with small differences.
Recombination in the region is the likely explanation for this change in MHC-Y haplotypes.
Chicken lines from the University of Arkansas were examined for MHC-Y haplotypes. It
was found that the Arkansas Lines also had variation in their haplotypes. The Arkansas MHC-Y
haplotypes were not consistent with the haplotypes found in the NIU Line. In the most complex
MHC-Y haplotype the number of fragments in the Arkansas line, and the range of the fragments
seen on the Southern blots exceeded that of the NIU line.
Eight commercial chicken lines were also examined for MHC-Y haplotypes. It was found
that the types in these lines were also unique and for the most part did not share similar
haplotype fragment patterns with the NIU and Arkansas Lines.
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The fragment patterns in the MHC-Y haplotypes were extremely variable overall, with
some haplotypes having only 2 fragments while others had up to 15 fragments. This variability in
the Southern blots indicates that certain haplotypes have more copies of MHC-Y genes than
other haplotypes. To examine the idea of copy number variation further, the techniques of DGGE
and qPCR were employed.
In Chapter 3 I used Polymerase Chain Reaction – Denaturing Gradient Gel
Electrophoresis (PCR-DGGE) to determine copy number variation in MHC-Y haplotypes. I also
experimented with this technique to determine whether it could be used to distinguishing MHCY haplotypes, in order to replace Southern blotting in typing for MHC-Y. Primers were made to
include entire exons 2, 3, 4 and 5 of the MHC-Y. I determined that DGGE was not as sensitive as
RFLP typing and it could not be used to distinguish the individual MHC-Y haplotypes. The
technique did prove useful in confirming that there is copy number variation in the MHC-Y
region.
In Chapter 4, quantitative real-time PCR (qPCR) was used to examine copy number
variation in the MHC-Y region. This technique did confirm relative copy number variation for
different MHC-Y haplotypes, with NIU Line Y1, and Y2 haplotypes having the lowest copy and
haplotypes Y3 and Y6 having the highest number of copies of MHC-Y genes.
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